StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Zoladex (goserelin) — Europe YoY CER by Quarter

Zoladex (goserelin) — Europe YoY CER (%) (%)

QuarterlyAnnual

AstraZeneca Zoladex (goserelin) — Europe YoY CER: 5.0% in Q2 2026, up 18.0 pts from a year earlier.

Latest, Q2 2026
5.0%
Period ended Jun 30, 2026
Change on a year earlier
+18.0 pts
-13.0% in Q2 2025
History
23 quarters
Since Q4 2020
Sources
23
Documents cited below

Where the Q2 2026 figure comes from

“|| Zoladex | | 304 | | 7 | | 2 | | 5 | | 10 | | 239 | | 9 | | 4 | | 42 | | 10 | | 5 | | 18 | | ( 23 ) | | ( 24 )”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K / 20-F Product Sales Table.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedZoladex (goserelin) — Europe YoY CER (%) (%)Year on yearSource
Q2 2026Jun 30, 20265.0%+18.0 ptsForm 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 20264.0%+6.0 ptsForm 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 202515.0%+12.0 ptsForm 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 202513.0%+3.0 ptsForm 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 2025-13.0%-34.0 ptsForm 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 2025-2.0%-8.0 ptsForm 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 20243.0%+5.0 ptsForm 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 202410.0%+16.0 ptsForm 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 202421.0%+20.0 ptsForm 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 20246.0%+5.0 ptsForm 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 2023-2.0%-12.0 ptsForm 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 2023-6.0%-1.0 ptsForm 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 20231.0%-2.0 ptsForm 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 20231.0%+4.0 ptsForm 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 202210.0%+12.0 ptsForm 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 2022-5.0%-6.0 ptsForm 6-K FY2022Q3 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Zoladex (goserelin) — Europe YoY CER (%), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-zoladex-eu-cer-yoy

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.